RT Journal Article
SR Electronic
T1 Critical Appraisal of Artificial Intelligence–Enabled Imaging Tools Using the Levels of Evidence System
JF American Journal of Neuroradiology
JO Am. J. Neuroradiol.
FD American Society of Neuroradiology
SP E21
OP E28
DO 10.3174/ajnr.A7850
VO 44
IS 5
A1 N. Pham
A1 V. Hill
A1 A. Rauschecker
A1 Y. Lui
A1 S. Niogi
A1 C.G. Fillipi
A1 P. Chang
A1 G. Zaharchuk
A1 M. Wintermark
YR 2023
UL http://www.ajnr.org/content/44/5/E21.abstract
AB SUMMARY: Clinical adoption of an artificial intelligence–enabled imaging tool requires critical appraisal of its life cycle from development to implementation by using a systematic, standardized, and objective approach that can verify both its technical and clinical efficacy. Toward this concerted effort, the ASFNR/ASNR Artificial Intelligence Workshop Technology Working Group is proposing a hierarchal evaluation system based on the quality, type, and amount of scientific evidence that the artificial intelligence–enabled tool can demonstrate for each component of its life cycle. The current proposal is modeled after the levels of evidence in medicine, with the uppermost level of the hierarchy showing the strongest evidence for potential impact on patient care and health care outcomes. The intended goal of establishing an evidence-based evaluation system is to encourage transparency, foster an understanding of the creation of artificial intelligence tools and the artificial intelligence decision-making process, and to report the relevant data on the efficacy of artificial intelligence tools that are developed. The proposed system is an essential step in working toward a more formalized, clinically validated, and regulated framework for the safe and effective deployment of artificial intelligence imaging applications that will be used in clinical practice.AIartificial intelligenceHIPPAHealth Insurance Portability and Accountability Act